SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 33.00 |
| Enterprise Value ($M) | 22.52 |
| Book Value ($M) | -5.05 |
| Book Value / Share | -0.05 |
| Price / Book | -6.54 |
| NCAV ($M) | -8.79 |
| NCAV / Share | -0.09 |
| Price / NCAV | -3.76 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.99 |
| Return on Equity (ROE) | -6.07 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.86 |
| Current Ratio | 0.86 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 17.54 |
| Assets | 21.28 |
| Liabilities | 26.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.81 |
| Operating Income | -30.74 |
| Net Income | -30.16 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -38.86 |
| Cash from Investing | -0.63 |
| Cash from Financing | 15.64 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 548,489 | 1,660,429 | 33.03 | |
| 3,188,167 | 9,172,228 | 34.76 | |
| 41,340 | 51,661 | 80.02 | |
| 64,307 | 22,500 | 285.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYCN – Cyclerion Therapeutics, Inc. | CYRX – Cryoport, Inc. |
| CYTH – Cyclo Therapeutics, Inc. | DERM – Journey Medical Corporation |
| DMAC – DiaMedica Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io